“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
As part of the push to implement the NIH Data Management and Sharing Policy on January 25, 2023, the NIH has released Informed Consent for…
FDA’s Center for Drug Evaluation and Research (CDER) has launched their new Accelerating Rare disease Cures (ARC) Program to accelerate the development of safe and…
In December of 2021, the National Institutes of Health (NIH) released the ClinicalTrials.gov Beta to improve the interface and search functions as well as a…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
Led by the U.S. Department of Health and Human Services’ Office on Women’s Health (OWH), National Women’s Health Week from May 8–14, 2022 is an…
Started in 1949, by Mental Health America (MHA), Mental Health Awareness Month is a time to raise awareness and educate the public about mental illness,…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
The FDA has released the guidance document “Drug Products, Including Biological Products, that Contain Nanomaterials – Guidance for Industry.” It finalizes the draft guidance issued…
In April of 2021, the FDA issued its first Notice of Noncompliance to a company failing to submit required summary results information to ClinicalTrials.gov. This…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
